Speaking Faculty
Rick Doblin, Ph.D.Founder & Executive Director
Multidisciplinary Association of Psychedelic Studies (MAPS)
Charles Nichols, Ph.D.Prof., Dept. of Pharmacology & Experimental Therapeutics
LSU Health Sciences Center
Frederick Barrett, Ph.D.Assistant Professor of Psychiatry & Behavioral Sciences
Johns Hopkins School of Medicine
Bryan Roth, MD, Ph.D.Michael Hooker Distinguished Professor
U. of North Carolina School of Medicine
Javier Gonzalez Maeso, Ph.D.Professor of Physiology and Biophysics
VCU School of Medicine
Alan Kozikowski, Ph.D.Chief Scientific Officer
Bright Minds
Henri Sant-CassiaFounding Partner
The Conscious Fund
JR RahnCo-Founder,
Co-CEO
MindMed
Boris Heifets, MD, Ph.D.Assistant Professor, Dept. of Anesthesiology, Perioperative & Pain Medicine
Stanford University School of Medicine
Neiloufar Family, Ph.D.Psychiatric Research Director
Eleusis
Stephen Ross, MDAssociate Director
NYU Langone Health Center for Psychedelic Medicine
Shlomi RazChief Executive Officer
Eleusis
Jesper Langgaard Kristensen, Ph.D.Prof., Medicinal Chemistry, Dept. of Drug Design & Pharmacology/Chief Scientific Officer
University of Copenhagen/Lophora
Judy Ashworth, MDVice President, Rx Strategic Services and Chief Medical Officer
Pinney Associates
Marion Coe, Ph.D.Scientist
Pinney Associates
Timothy KoChief Executive Officer
Entheon Biomedical
Tristan McClure-Begley, Ph.D.Program Manager, Focused Pharma
Defense Advanced Research Projects Agency (DARPA)
Revati Shreeniwas, MDChief Medical Officer
Bright Minds
Jack Henningfield, Ph.D.VP, Research, Health Policy, & Abuse Liability
Pinney Associates
